We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Distribution Agreement for Anesthesia System

By HospiMedica staff writers
Posted on 05 Nov 2002
Print article
An exclusive agreement granting distribution rights for an anesthesia system throughout North America to Invivo Research, Inc. has been announced by the manufacturer, Draeger Medical.

The anesthesia system, called Narkomed MRI-2, is designed to be used in a magnetic resonance imaging (MRI) environment. Invivo Research will distribute the system through its sales channels in North America under the name of Magnitudeas, which will be part of the Invivo Magnitude product line. This line comprises an MRI-compatible patient monitor and a remote patient monitor.

"We are very happy to be affiliated with Invivo Research. They have been a leader in the MRI patient monitoring industry for a number of years. Together with Invivo Research, we can grow within the MRI market and achieve our ambitious goals in North America,” said Ruben Derderian, president and CEO, Draeger Medical.




Related Links:
Draeger
Invivo
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Washer Disinfector
Tiva 2
New
6-Channel ECG System
SE600

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.